Skip to main content
. 2020 Jul 2;10:10921. doi: 10.1038/s41598-020-67872-z

Figure 2.

Figure 2

Identified candidate genes with somatic and/or germline single nucleotide variations in iPSCs of TOF patients and healthy relatives. (A) SNVs identified in blood and/or pooled iPSCs (n = 3). (B) Sequencing coverage and base quality for SNVs in blood (light red) or iPSCs only (cyan). (C) Filtering for disease candidate genes with somatic and germline SNVs. (D) Candidate genes with somatic SNVs. Whole genome sequencing was performed for pooled iPSCs and identified somatic SNVs were verified clone-wise (iPSC-specific) by whole transcriptome sequencing (RNA-seq). The individual somatic SNVs are marked in red. SNVs confirmed by Sanger sequencing are marked in bold. SNVs not verified by RNA-seq but confirmed by Sanger are marked by bold brackets. MAF: minor allele frequency; R: Spearman correlation; SNVs: single nucleotide variations; TPM: transcripts per kilobase million; WGS: whole genome sequencing.